ArticlePloS one2025
Genomic characterization and fermentation study of the endophyte Stemphylium sp. (Aa22), a producer of bioactive alkyl-resorcinols.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Untapped microbial factories for next-generation therapeutics: Endophytic fungi of medicinal plants.Microbial cell factories · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The genome of the previously described endophytic fungus Stemphylium sp. (strain Aa22) has been sequenced to near completion. Phylogenomic analysis placed strain Aa22 in close proximity to Stemphylium lycopersici. Strain Aa22 had been previously reported as the producer of the bioactive alkyl-resorcinol stemphol and derivative stempholones A and B in solid culture on rice. Genome mining for biosynthetic gene clusters (BGCs) identified 38 genomic regions predicted to encode secondary metabolites production. Among them, a single type III polyketide synthase (T3PKS) that shared similarity with other fungal T3PKSs was identified. T3PKSs are responsible for the biosynthesis of alkyl-resorcinols from fatty acyl-CoA substrates. This makes the identified T3PKS gene a likely candidate for stempholone biosynthesis and a target for future manipulation to enhance production of bioactive alkyl-resorcinols. We also studied the production of these compounds in solid rice media and in liquid PDB medium with or without the addition of talcum powder. The highest extract yield was obtained with PDB cultures, and GC-MS analysis revealed the presence of high levels of the bioactive compound stempholone A, along with two unidentified compounds. Addition of talcum powder suppressed stempholone A production and reduced chemical diversity, with accumulation of oleamide. In contrast, the rice solid media fermentation resulted in methylated fatty acids and oleamide, with no detectable stempholone.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.